Selected research
Market Structure
Global Magnesium Sulfate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Magnesium Sulfate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Magnesium Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Magnesium Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Magnesium Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Magnesium Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Magnesium Sulfate Injection include AdvaCare Pharma, American Regent, Exela, WG Critical Care, X-Gen, Beijing Yimin Pharmaceutical, Chengdu Brilliant Pharmaceutical, Fresenius Kabi and Sinopharm Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Magnesium Sulfate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Magnesium Sulfate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Magnesium Sulfate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Magnesium Sulfate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Magnesium Sulfate Injection Segment by Company
AdvaCare Pharma
American Regent
Exela
WG Critical Care
X-Gen
Beijing Yimin Pharmaceutical
Chengdu Brilliant Pharmaceutical
Fresenius Kabi
Sinopharm Group
Hangzhou Minsheng Pharmaceutical Industry Group
Hebei Tiancheng Pharmaceutical
Pfizer
Jiangsu Huayang Pharmacy
Jinling Pharmaceutical
Shanghai Xudong Help
Wuhan Jiuan Pharmaceutical
Magnesium Sulfate Injection Segment by Type
500mg/ml
40mg/ml
250mg/ml
10mg/ml
Others
Magnesium Sulfate Injection Segment by Application
Clinics
Hospital
Recovery Center
Magnesium Sulfate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Magnesium Sulfate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Magnesium Sulfate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Magnesium Sulfate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Magnesium Sulfate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Magnesium Sulfate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Magnesium Sulfate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Magnesium Sulfate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/ml
- 40mg/ml
- 250mg/ml
- 10mg/ml
- Others
Applications
- Clinics
- Hospital
- Recovery Center
Companies covered
- AdvaCare Pharma
- American Regent
- Exela
- WG Critical Care
- X-Gen
- Beijing Yimin Pharmaceutical
- Chengdu Brilliant Pharmaceutical
- Fresenius Kabi
- Sinopharm Group
- Hangzhou Minsheng Pharmaceutical Industry Group
- Hebei Tiancheng Pharmaceutical
- Pfizer
- Jiangsu Huayang Pharmacy
- Jinling Pharmaceutical
- Shanghai Xudong Help
- Wuhan Jiuan Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Magnesium Sulfate Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Magnesium Sulfate Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Magnesium Sulfate Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Magnesium Sulfate Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Magnesium Sulfate Injection Market Dynamics
- 2.1 Magnesium Sulfate Injection Industry Trends
- 2.2 Magnesium Sulfate Injection Industry Drivers
- 2.3 Magnesium Sulfate Injection Industry Opportunities and Challenges
- 2.4 Magnesium Sulfate Injection Industry Restraints
3 Magnesium Sulfate Injection Market by Manufacturers
- 3.1 Global Magnesium Sulfate Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Magnesium Sulfate Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Magnesium Sulfate Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Magnesium Sulfate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Magnesium Sulfate Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Magnesium Sulfate Injection Manufacturers, Product Type & Application
- 3.7 Global Magnesium Sulfate Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Magnesium Sulfate Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Magnesium Sulfate Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Magnesium Sulfate Injection Tier 1, Tier 2, and Tier 3
4 Magnesium Sulfate Injection Market by Type
- 4.1 Magnesium Sulfate Injection Type Introduction
- 4.1.1 500mg/ml
- 4.1.2 40mg/ml
- 4.1.3 250mg/ml
- 4.1.4 10mg/ml
- 4.1.5 Others
- 4.2 Global Magnesium Sulfate Injection Sales by Type
- 4.2.1 Global Magnesium Sulfate Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Magnesium Sulfate Injection Sales by Type (2021-2032)
- 4.2.3 Global Magnesium Sulfate Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Magnesium Sulfate Injection Revenue by Type
- 4.3.1 Global Magnesium Sulfate Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Magnesium Sulfate Injection Revenue by Type (2021-2032)
- 4.3.3 Global Magnesium Sulfate Injection Revenue Market Share by Type (2021-2032)
5 Magnesium Sulfate Injection Market by Application
- 5.1 Magnesium Sulfate Injection Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospital
- 5.1.3 Recovery Center
- 5.2 Global Magnesium Sulfate Injection Sales by Application
- 5.2.1 Global Magnesium Sulfate Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Magnesium Sulfate Injection Sales by Application (2021-2032)
- 5.2.3 Global Magnesium Sulfate Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Magnesium Sulfate Injection Revenue by Application
- 5.3.1 Global Magnesium Sulfate Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Magnesium Sulfate Injection Revenue by Application (2021-2032)
- 5.3.3 Global Magnesium Sulfate Injection Revenue Market Share by Application (2021-2032)
6 Global Magnesium Sulfate Injection Sales by Region
- 6.1 Global Magnesium Sulfate Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Magnesium Sulfate Injection Sales by Region (2021-2032)
- 6.2.1 Global Magnesium Sulfate Injection Sales by Region (2021-2026)
- 6.2.2 Global Magnesium Sulfate Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Magnesium Sulfate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Magnesium Sulfate Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Magnesium Sulfate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Magnesium Sulfate Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Magnesium Sulfate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Magnesium Sulfate Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Magnesium Sulfate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Magnesium Sulfate Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Magnesium Sulfate Injection Revenue by Region
- 7.1 Global Magnesium Sulfate Injection Revenue by Region
- 7.1.1 Global Magnesium Sulfate Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Magnesium Sulfate Injection Revenue by Region (2021-2026)
- 7.1.3 Global Magnesium Sulfate Injection Revenue by Region (2027-2032)
- 7.1.4 Global Magnesium Sulfate Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Magnesium Sulfate Injection Revenue (2021-2032)
- 7.2.2 North America Magnesium Sulfate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Magnesium Sulfate Injection Revenue (2021-2032)
- 7.3.2 Europe Magnesium Sulfate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Magnesium Sulfate Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Magnesium Sulfate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Magnesium Sulfate Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Magnesium Sulfate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 AdvaCare Pharma
- 8.1.1 AdvaCare Pharma Company Information
- 8.1.2 AdvaCare Pharma Business Overview
- 8.1.3 AdvaCare Pharma Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 AdvaCare Pharma Magnesium Sulfate Injection Product Portfolio
- 8.1.5 AdvaCare Pharma Recent Developments
- 8.2 American Regent
- 8.2.1 American Regent Company Information
- 8.2.2 American Regent Business Overview
- 8.2.3 American Regent Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 American Regent Magnesium Sulfate Injection Product Portfolio
- 8.2.5 American Regent Recent Developments
- 8.3 Exela
- 8.3.1 Exela Company Information
- 8.3.2 Exela Business Overview
- 8.3.3 Exela Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Exela Magnesium Sulfate Injection Product Portfolio
- 8.3.5 Exela Recent Developments
- 8.4 WG Critical Care
- 8.4.1 WG Critical Care Company Information
- 8.4.2 WG Critical Care Business Overview
- 8.4.3 WG Critical Care Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 WG Critical Care Magnesium Sulfate Injection Product Portfolio
- 8.4.5 WG Critical Care Recent Developments
- 8.5 X-Gen
- 8.5.1 X-Gen Company Information
- 8.5.2 X-Gen Business Overview
- 8.5.3 X-Gen Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 X-Gen Magnesium Sulfate Injection Product Portfolio
- 8.5.5 X-Gen Recent Developments
- 8.6 Beijing Yimin Pharmaceutical
- 8.6.1 Beijing Yimin Pharmaceutical Company Information
- 8.6.2 Beijing Yimin Pharmaceutical Business Overview
- 8.6.3 Beijing Yimin Pharmaceutical Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Beijing Yimin Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 8.6.5 Beijing Yimin Pharmaceutical Recent Developments
- 8.7 Chengdu Brilliant Pharmaceutical
- 8.7.1 Chengdu Brilliant Pharmaceutical Company Information
- 8.7.2 Chengdu Brilliant Pharmaceutical Business Overview
- 8.7.3 Chengdu Brilliant Pharmaceutical Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Chengdu Brilliant Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 8.7.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 8.8 Fresenius Kabi
- 8.8.1 Fresenius Kabi Company Information
- 8.8.2 Fresenius Kabi Business Overview
- 8.8.3 Fresenius Kabi Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Fresenius Kabi Magnesium Sulfate Injection Product Portfolio
- 8.8.5 Fresenius Kabi Recent Developments
- 8.9 Sinopharm Group
- 8.9.1 Sinopharm Group Company Information
- 8.9.2 Sinopharm Group Business Overview
- 8.9.3 Sinopharm Group Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sinopharm Group Magnesium Sulfate Injection Product Portfolio
- 8.9.5 Sinopharm Group Recent Developments
- 8.10 Hangzhou Minsheng Pharmaceutical Industry Group
- 8.10.1 Hangzhou Minsheng Pharmaceutical Industry Group Company Information
- 8.10.2 Hangzhou Minsheng Pharmaceutical Industry Group Business Overview
- 8.10.3 Hangzhou Minsheng Pharmaceutical Industry Group Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hangzhou Minsheng Pharmaceutical Industry Group Magnesium Sulfate Injection Product Portfolio
- 8.10.5 Hangzhou Minsheng Pharmaceutical Industry Group Recent Developments
- 8.11 Hebei Tiancheng Pharmaceutical
- 8.11.1 Hebei Tiancheng Pharmaceutical Company Information
- 8.11.2 Hebei Tiancheng Pharmaceutical Business Overview
- 8.11.3 Hebei Tiancheng Pharmaceutical Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hebei Tiancheng Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 8.11.5 Hebei Tiancheng Pharmaceutical Recent Developments
- 8.12 Pfizer
- 8.12.1 Pfizer Company Information
- 8.12.2 Pfizer Business Overview
- 8.12.3 Pfizer Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Pfizer Magnesium Sulfate Injection Product Portfolio
- 8.12.5 Pfizer Recent Developments
- 8.13 Jiangsu Huayang Pharmacy
- 8.13.1 Jiangsu Huayang Pharmacy Company Information
- 8.13.2 Jiangsu Huayang Pharmacy Business Overview
- 8.13.3 Jiangsu Huayang Pharmacy Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Jiangsu Huayang Pharmacy Magnesium Sulfate Injection Product Portfolio
- 8.13.5 Jiangsu Huayang Pharmacy Recent Developments
- 8.14 Jinling Pharmaceutical
- 8.14.1 Jinling Pharmaceutical Company Information
- 8.14.2 Jinling Pharmaceutical Business Overview
- 8.14.3 Jinling Pharmaceutical Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Jinling Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 8.14.5 Jinling Pharmaceutical Recent Developments
- 8.15 Shanghai Xudong Help
- 8.15.1 Shanghai Xudong Help Company Information
- 8.15.2 Shanghai Xudong Help Business Overview
- 8.15.3 Shanghai Xudong Help Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Shanghai Xudong Help Magnesium Sulfate Injection Product Portfolio
- 8.15.5 Shanghai Xudong Help Recent Developments
- 8.16 Wuhan Jiuan Pharmaceutical
- 8.16.1 Wuhan Jiuan Pharmaceutical Company Information
- 8.16.2 Wuhan Jiuan Pharmaceutical Business Overview
- 8.16.3 Wuhan Jiuan Pharmaceutical Magnesium Sulfate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Wuhan Jiuan Pharmaceutical Magnesium Sulfate Injection Product Portfolio
- 8.16.5 Wuhan Jiuan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Magnesium Sulfate Injection Value Chain Analysis
- 9.1.1 Magnesium Sulfate Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Magnesium Sulfate Injection Production Mode & Process
- 9.2 Magnesium Sulfate Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Magnesium Sulfate Injection Distributors
- 9.2.3 Magnesium Sulfate Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst